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From the Editor’s Desk
PRIMUM NON NOCERE — 
TO YOURSELF                     
Hurry up, hurry up, hurry up, hurry up 
Can’t waste time, can’t waste time, can’t waste 
time, can’t waste time 
When you’re racing with the clock 
When you’re racing with the clock 
And the second hand doesn’t understand 
That your back may break and your fingers ache 
And your constitution isn’t made of rock
It’s a losing race when you’re racing with the 
Racing racing racing with the clock 
The Pajama Game
Richard Adler and Jerry Ross, 1954
Australia-wide, doctors are returning to work 
after a break, perhaps even to circumstances 
similar to those so poignantly captured above: 
changing schedules to better meet the incessant 
demands of patients, reams of paperwork, 
escalating red tape and endless requests to serve 
on this or that committee. Indeed, their lives are 
subsumed by service to others before self. 
“No worries”, many say, “we are task-oriented,
compulsive and perfectionists. We can cope”.
But take time out to answer either yes or no to 
the following questions*:
1. Are you highly achievement-oriented?
2. Do you tend to withdraw from offers of support?
3. Do you have difficulty delegating responsibilities 
to others, including patients?
4. Do you prefer to work alone?
5. Do you avoid discussing problems with others?
6. Do you externalise blame?
7. Are your work relationships asymmetrical? 
(ie, are you always giving?)
8. Is your personal identity bound up with your 
work role or professional identity?
9. Do you often overload yourself — have a 
difficult time saying no?
10.Is there a lack of opportunities for positive and 
timely feedback outside your professional or 
work role?
11.Do you abide by the laws “don’t talk, don’t trust, 
don’t feel”?
The more “yes” responses, the greater your 
risk of professional burnout.
The solution?
Primum non nocere — to yourself.
Martin B Van Der Weyden
* Center for Professional Well-Being, Durham, 
North Carolina, USA.
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Letters
Probable transmission of 
meningococcal disease on 
a school bus
Frank H Beard,* Jeremy M McAnulty,† 
John W Tapsall,‡ Angelo M Zaia§
* Senior Medical Officer, Communicable Diseases Unit, 
Queensland Health, 147-163 Charlotte Street, 
Brisbane, QLD 4001; † Director, Communicable
Diseases Branch, NSW Health, Sydney, NSW; ‡ Senior 
Specialist in Microbiology, SEALS, Prince of Wales 
Hospital, Sydney, NSW; § Molecular Biologist, 
University of Melbourne, VIC. 
Frank_Beard@health.qld.gov.au
TO THE EDITOR: We report two cases of
serogroup B meningococcal disease, caused
by genotypically indistinguishable organ-
isms, where transmission is likely to have
occurred on a school bus. To our know-
ledge, transmission of meningococcal dis-
ease on a bus has been reported only once
before.1
In June 2005, two cases of serogroup B
meningococcal disease in teenagers from the
same school were reported to the Northern
Sydney Public Health Unit. Patient 1 had
symptoms of fever, headache, vomiting, and
an erythematous rash. Two days after onset
of this patient’s symptoms, Patient 2 also
developed fever, headache and vomiting.
In both cases, diagnosis of meningococcal
disease was confirmed by polymerase chain
reaction (PCR) testing of cerebrospinal fluid
(CSF). CSF cell counts were consistent with
bacterial meningitis, but blood and CSF
culture were negative, despite lack of prior
antibiotic administration.
The patients were in different school
years. No obvious links, such as common
classes, sporting teams, or mutual friends,
could be found. However, they reported
travelling on the same buses to and from
school each day. These buses carry up to 78
students (53 seated and 25 standing) from
the patients’ school and other nearby
schools. The patients reported that the buses
were usually crowded.
Chemoprophylaxis was provided 8–9
days after symptom onset in Patient 2 to 132
students who claimed to have travelled on
these buses during the exposure period.
The two patients recovered fully and
returned to school. No subsequent cases of
meningococcal disease have occurred at the
school.
In the absence of meningococcal isolates,
porA/porB genotyping2,3 was conducted on
the meningococcal DNA contained in the
CSF samples, and yielded identical
sequences. While genotyping is not rou-
tinely conducted, porA/porB sequence
nomenclature can be equated with serotype/
subserotype (phenotypic expression of porA/
porB). All 38 serogroup B isolates to date in
NSW in 2005 have had serotyping/subsero-
typing performed, with no other cases hav-
ing a serotype/subserotype equivalent to that
of the two cases reported here. This sup-
ports the school bus as the most likely
setting of transmission, given the lack of
mutual friends and activities identified
between the two cases.
Asymptomatic nasopharyngeal carriage of
meningococci is common, with about 10%
of individuals being carriers at any one
time.4 While crowding and close contact
increase transmission of meningococci, fac-
tors leading to invasive disease are poorly
understood.5 Antibiotic chemoprophylaxis
is given to close contacts to eradicate
nasopharyngeal carriage and limit disease
spread.5 However, the absence of further
cases among the 132 fellow travellers in this
setting does not provide evidence of effect-
iveness of the chemoprophylaxis, given that
the secondary attack rate, even in close
household contacts, has been estimated at
2–4 per 1000 people.6
Current Australian guidelines recommend
that, in school-based outbreaks, chemo-
prophylaxis be considered for a wider group
than solely close contacts of a household
nature.7 This report provides evidence to
support chemoprophylaxis in similar cir-
cumstances, where linked cases are identi-
fied in school bus co-travellers, and no
other, more specific natural grouping makes
epidemiological sense.
1 Harrison LH, Armstrong CW, Jenkins SR, et al. A
cluster of meningococcal disease on a school bus
following epidemic influenza. Arch Intern Med
1991; 151: 1005-1009.
2 Sacchi CT, Lemos AP, Brandt ME, et al. Proposed
standardization of Neisseria meningitidis PorA vari-
able-region typing nomenclature. Clin Diagn Lab
Immunol 1998; 5: 845-855.
3 Sacchi CT, Lemos AP, Whitney AM, et al. Correlation
between serological and sequencing analyses of
the PorB outer membrane protein in the Neisseria
meningitidis serotyping system. Clin Diagn Lab
Immunol 1998; 5: 348-354.
4 Yazdankhah SP, Caugant DA. Neisseria menin-
gitidis: an overview of the carriage state. J Med
Microbiol 2004; 53: 821-832.
5 Tzeng YL, Stephens DS. Epidemiology and patho-
genesis of Neisseria meningitidis. Microbes Infect
2000; 2: 687-700.
6 Raghunathan PL, Bernhardt SA, Rosenstein NE.
Opportunities for control of meningococcal disease
in the United States. Annu Rev Med 2004; 55: 333-
353.
7 Communicable Diseases Network Australia. Guide-
lines for the early clinical and public health manage-
ment of meningococcal disease in Australia.
Canberra: Commonwealth of Australia, 2001. ❏
Willingness of general 
practitioners to participate 
in enhanced primary care 
discharge care planning
David B Preen,* Belinda E S Bailey,† 
Alan Wright‡
* Research Associate, School of Population Health, 
University of Western Australia, 35 Stirling Highway, 
Crawley, WA 6009; † State Manager, Royal Australian 
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Faculty, Perth, WA; ‡ Hospital Liaison General 
Practitioner, Department of General Medicine, 
Fremantle Hospital and Health Services, Perth, WA. 
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TO THE EDITOR: The care of patients at
the time of hospital discharge and on
returning home is often neglected, and has
implications for those needing multidiscip-
linary care. Research has shown that dis-
charge planning can produce better health
outcomes, facilitate the patient’s and the
general practitioner’s involvement with dis-
charge care, and improve communication
between hospital and general practice serv-
ices.1-3
To encourage GPs to be involved in dis-
charge care planning for patients with
chronic diseases, there are Enhanced Pri-
mary Care (EPC)-specific Medicare Benefits
Schedule (MBS) Items for contributing as a
team member to EPC discharge care plan-
ning (Item 728), and for review at 3 months
post-discharge (Item 724).4 However, the
fact that < 1% of claims for EPC care plans
are for discharge-related items has been
attributed to barriers to GPs’ involvement in
discharge planning, or their unwillingness
or inability to initiate such a process rather
than simply participate.5 Further, little evi-
dence exists that, given the opportunity, GPs
are willing to be involved as a team member
in this process.
In a recent study of ours investigating
EPC discharge care planning for chroni-
cally ill patients,3 we required GPs to com-
prehensively review and comment (in
writing) on discharge plans developed by
the hospital. GPs also performed a follow-
up consultation within 7 days of discharge
and completed a questionnaire. We found
that 90.1% of 91 GPs in the intervention
arm of the study willingly contributed to
discharge care planning for their patients,
indicating that, when offered input into
planning discharge and post-discharge
care, GPs are willing to fulfil such a role.
Further, this finding, in addition to the
high questionnaire response rate of trial
GPs (80.6%), indicates the importance of90 MJA • Volume 184 Number 2 • 16 January 2006
LETTERSthis issue to GPs and the belief that GPs are
not sufficiently included in discharge proc-
esses.
Additional results from a follow-up sur-
vey, at 28 days post-discharge, of those GPs
who participated in discharge planning (n =
91, 70.3% response) showed that only 42%
of GPs claimed the MBS Item 728 ($39.80
in 2002, at the time of the study). Results
from a subsequent survey (n = 91, 45.1%
response) suggested that even fewer (about
15% of respondents) claimed reimburse-
ment for a 3-month care plan review (Item
724, $98.20), although we do not have data
on the number of 3-month reviews per-
formed.
The reasons given for not claiming these
Items included poor understanding of the
Item and claiming procedures, and a belief
that excessive administration was required
to claim the increasing number of MBS
items. In the light of sanctions for admin-
istrative claiming errors, this may explain
the low claim counts for these Items.
However, the most common response was
that input into the discharge care plan
was, in their opinion, not sufficient to
justify reimbursement, even with the extra
time required for care plan review and
post-discharge follow-up. This suggests
that GPs do not simply view EPC dis-
charge care planning as a revenue raising
exercise, but rather as quality patient care.
Further, it may indicate an undervaluation
by some GPs of their role in hospital-
driven processes.
Considering the evidence in support of
discharge care planning for improving
quality of care, focus should be directed
towards ways of encouraging this process,
other than simply providing a financial
incentive.
1 Naylor MD, Brooten DA, Campbell RL, et al. Transi-
tional care of older adults hospitalised with heart
failure: a randomized, controlled trial. J Am Geriatr
Soc 2004; 52: 675-684.
2 Atienza F, Anguita M, Martinez-Alzamora N, et al.
PRICE Study Group. Multicenter randomized trial of
a comprehensive hospital discharge and outpatient
heart failure management program. Eur J Heart Fail
2004; 6: 643-652.
3 Preen DB, Bailey B, Wright A, et al. Effects of a
multidisciplinary, post-discharge continuance of
care intervention on quality-of-life, discharge satis-
faction and hospital length-of-stay: a randomised
controlled trial. Int J Qual Health Care 2005; 17:
43-51.
4 Enhanced Primary Care Manual: Standards and
Guidelines for the Enhanced Primary Care, Medi-
care Benefits Schedule Items. The Royal Austral-
ian College of General Practitioners, 2000.
Canberra: Australian Government Department of
Health and Aged Care. Available at: http://
www.racgp.org.au/downloads/20010316epc.pdf
(accessed Dec 2005).
5 Wilkinson D, Mott K, Morey S, et al. Evaluation of
the Enhanced Primary Care (EPC) Medicare Benefits
Schedule (MBS) Items and the General Practice
Education, Support and Community Linkages Pro-
gram (GPESCL) — final report. Canberra: Australian
Government Department of Health and Ageing,
2003 Available at: http://www.health.gov.au/epc/
epcevaluation.htm (accessed Dec 2005). ❏
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TO THE EDITOR: We are concerned that
the Northern Territory’s regulations on kava
have not succeeded in controlling its availa-
bility in Arnhem Land (the north-eastern
region of the NT). Under the Kava Manage-
ment Act 1998 (NT), one wholesaler is
licensed to supply kava (Piper methysticum
Forst. f.) to four licensed retailers in Arnhem
Land Aboriginal communities.1
“Kava Management Plans” in “Kava
Licence Areas” permit retailers to supply
600–800 g per week of kava powder to each
purchaser1 — more than double the known
harmful consumption levels (240–440 g per
week).2 Legal kava supplied will reach 26
tonnes in 2005 (worth $3.6 million), with aMJA • Volume 184 Number 2 • 16 January 2006 91
History of kava use and retail value ($ million) on the legal and black markets in Arnhem Land, Northern Territory, since 
1982, extrapolated to the end of 2005*
Arnhem Land people from Yirrkala begin 
using kava in 1982; use spreads to other 
Arnhem Land communities; trade is 
unregulated
Concern about adverse 
effects leads to 
regulation under 
Consumer Protection 
Act 1990 (NT)†
Kava becomes “prohib-
ited botanical” under 
national Food Standards 
Code 1994; NT 
regulations dismantled
Kava Management Act 1998 (NT) introduced; 
from May 2002, licensed kava supplied to 
four retailers
* Data on kava supplied were obtained from d’Abbs (for 1982–1993);3 were estimated from population surveys of kava use (for 1994–1997); were estimated from kava 
seized by Police and Licensing Inspectors (for illegal use, 1998–2005) (seizures were estimated to account for 14% of the illegal kava supplied, based on correlation with 
population surveys in 1999 and 2000); and were based on the licensed wholesaler’s monthly figures, extrapolated to the end of 2005 (for legal use from May 2002). Retail 
value was calculated from data on kava supplied and regulated values of $100 per kg (1990–1993), $140 per kg (2002–2004) and $150 per kg (2005), or a black market value 
of $250 per kg.2 † Approval required from Minister for communities to supply kava. pa = per annum. ◆
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LETTERSpersistent illegal trade adding 8 tonnes,
worth perhaps $2 million (Box). Two pro-
posed additional retail licences1 will
increase kava’s availability.
Kava’s social and economic effects remain
an ongoing concern. The region’s commu-
nity-controlled health service attributes to
kava abuse an accelerated decline in partici-
pation in traditional ceremonies and mortu-
ary rites in some localities. Kava is the
psychoactive substance with greatest impact
on the financial resources of communities
and individuals in Arnhem Land.2
Kava’s health effects include seizures and
extreme weight loss in heavy users (up to
20% of body mass), similar to that seen in
anorexia nervosa.4 Extreme weight loss, evi-
dent during the 1980s, has re-emerged in
the region’s kava users (MW Yunupingu,
unpublished observations). Raised total and
low-density lipoprotein (LDL) cholesterol
levels4 add to unresolved concerns that
heavy kava use may be a risk factor for
cardiovascular disease and sudden cardiac
deaths. Potential immunosuppressive effects
are suggested by relative lymphocytopenia
in heavy kava users4 and by increased risk of
melioidosis.5 Raised levels of liver enzymes
(alkaline phosphatase and γ -glutamyltrans-
ferase), which reverse after ceasing moderate
kava use, should be monitored because of
fatal hepatotoxicity documented in users of
manufactured kava products available as
natural therapies.6
Given the scarcity of substance misuse
treatment services in the region, with no
effective treatments for kava misuse, con-
trolling supply is the only practical measure
to reduce kava-related harms. Tighter con-
trols on kava supply are urgently required
while licensees implement promised
demand-reduction and harm-minimisation
strategies.1 We recommend that:
• no further retail licences be granted until
kava supply is reduced;
• retail licensees supply no more than
440 g per week to individual kava consum-
ers;
• quantities permitted to be imported by
the wholesaler and supplied to retailers be
limited;
• kava selling prices be reviewed in the
light of trade-offs between higher prices to
reduce demand and minimal financial
drains on communities;
• rigorous enforcement be continued to
eliminate illegal kava dealing; and
• the Kava Management Act be reviewed to
facilitate these changes.
Acknowledgements: The research reported here is
supported by a National Health and Medical
Research Council Postdoctoral Training Fellowship.
Competing interests: Alan Clough has been a
member of the Northern Territory Licensing Com-
mission, the body responsible for licensing kava in
the Northern Territory.
1 Northern Territory of Australia. Kava. Darwin: North-
ern Territory Treasury, Racing, Gaming and Licens-
ing Div is ion, 2005. Avai lab le at : ht tp :/ /
www.nt.gov.au/ntt/licensing/kava.shtml (accessed
Sep 2005).
2 Clough AR. Enough! or too much. What is “exces-
sive” kava use in Arnhem Land? Drug Alcohol Rev
2003; 22: 43-51.
3 d’Abbs P. A review of kava control measures in the
Northern Territory. Darwin: Menzies School of
Health Research, 1993.
4 Clough AR, Jacups SP, Wang Z, et al. Health effects
of kava use in an eastern Arnhem Land community.
Intern Med J 2003; 33: 336-340.
5 Currie BJ, Fisher DA, Howard DM, et al. Endemic
melioidosis in tropical northern Australia: a 10-year
prospective study and review of the literature. Clin
Infect Dis 2000; 31: 981-986.
6 Currie BJ, Clough AR. Kava hepatoxicity with West-
ern herbal products: does it occur with traditional
kava use? Med J Aust 2003; 178: 421-422. ❏
Specialty training should not 
be exclusively hospital-based
John W Orchard
Visiting Fellow, South Sydney Sports Medicine, 
University of New South Wales, 111 Anzac Parade, 
Kensington, NSW 2033. johnorchard@msn.com.au
TO THE EDITOR: I congratulate Harris et
al1 on conducting a survey that identified
aspects of specialty training that are difficult
for female doctors and doctors with partners
and/or children.
However, there are some omissions in their
article, which, although small, illustrate fur-
ther ways in which “specialty” training is
unfriendly to the aforementioned groups.
The authors purported to survey all medical
graduates registered in 2002 “with a clinical
college training program”. It appears that
registrars on the Australasian College of
Sports Physicians (ACSP) training program
were not included. This training program has
been in place since 1992, has been recog-
nised by the Health Insurance Commission
since 1999, and is most definitely a “clinical
college training program”. Although similar
in structure, there are two major differences
between the sports physician training pro-
gram and most other “specialty” training pro-
grams; namely, that the training is almost
entirely non-hospital based and that the
resulting qualification (the FACSP) is not
recognised as a “specialty” in Australia. In
2002, I believe that the Australasian College
of Sexual Health Physicians was in a similar
position to the ACSP, administering a “non-
specialty” clinical college training program
(which is now under the auspices of the
Royal Australasian College of Physicians).
The recognised specialties in Australia, with
the major exception of general practice, almost
all conduct most of their training in hospitals.
Not only are these hospital-based positions
relatively “female-unfriendly” and “parent-
unfriendly”, they don’t adequately train spe-
cialists for the majority of doctor–patient inter-
actions, which do not actually take place in
hospitals. They also contribute to the reality
that our “health” system is focused on treat-
ment of disease rather than prevention.2 Areas
such as women’s and men’s health, travel med-
icine and dietary medicine also exist within
our health system.3 Ideally, if we want a health
system that is better at actually promoting
health, these areas should also have formally
recognised training programs.
The conservatism of both the Australian
Government and the medical profession is
reflected in the process for recognising new
specialties, which has severely discouraged
community-based specialties from being
developed. The “choice” of specialty training
that Harris et al examined in their study was
limited by what was officially sanctioned in
2002. If it were accepted that there should
be more recognised specialty postgraduate
training positions in community-based
fields of medicine, then not only would our
medical system start to address its deficien-
cies in health promotion, but there would be
far more attractive training opportunities for
doctors who don’t wish to pursue full-time
hospital-based positions.
1 Harris MG, Gavel PH, Young JR. Factors influencing
the choice of specialty of Australian medical gradu-
ates. Med J Aust 2005; 183: 295-300. 
2 Corbett SJ. A Ministry for the Public’s Health: an
imperative for disease prevention in the 21st cen-
tury? Med J Aust 2005; 183: 254-257. 
3 Wilkinson D, Dick MB, Askew, DA. General practi-
tioners with special interests: risk of a good thing
becoming bad? Med J Aust 2005; 183: 84-86.  ❏
Malignant ascites and bacterial 
peritonitis
Ami Schattner,* Noa Ben-Baruch†
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TO THE EDITOR: We describe a patient
with malignant ascites and bacterial perito-
nitis, with no apparent intra-abdominal
source of infection.92 MJA • Volume 184 Number 2 • 16 January 2006
LETTERSA 56-year-old woman with advanced
breast cancer was admitted to hospital with
a 10-day history of diffuse abdominal pain,
umbilical tenderness, and increasing
abdominal girth. Breast cancer had been
diagnosed 13 years before admission (T2 N0
M0) and treated with radical mastectomy
and adjuvant chemotherapy. Five years
before admission, disease had recurred at
the chest wall, and 2 years before, liver
metastases were found. Chemotherapy had
failed, and her only current treatment com-
prised capecitabine and analgesics.
On admission, the patient had tachycar-
dia (110 beats per min), tachypnoea (26
breaths per min), blood pressure of 115/
80 mmHg, and no fever or signs of sepsis.
Examination showed evidence of local
recurrence around the left mastectomy scar,
and marked ascites with discoloration,
warmth, tenderness and a diffuse infiltration
over the umbilicus. There were no signs of
peritoneal irritation, nor leg oedema.
Blood test results were in the normal
range, except for mild leukocytosis
(10.6  109 cells/L; reference range [RR],
3.8–9.8  109 cells/L), with left shift (86%
neutrophils, and 6% lymphocytes; RR, up to
67% neutrophils, and at least 32% lym-
phocytes). X-ray did not show abdominal
free air. Abdominal computed tomography
revealed ascites, retroperitoneal lymph
nodes, omental and umbilical infiltration,
and the known liver metastases without
signs of portal hypertension.
Peritoneal tap removed 2800 mL of fluid.
Examination of the fluid revealed a white
blood cell count of 2  109 cells/L (80%
neutrophils), glucose concentration of
790 g/L, and albumin concentration of 22 g/
L (serum–ascites albumin gradient, 0.7; a
gradient < 1.1 indicates that the patient does
not have portal hypertension).
Gram stain of the ascitic fluid revealed
gram-positive cocci, and culture identified
Staphylococcus aureus. Cytological examina-
tion showed sheets of atypical enlarged epi-
thelial cells highly suggestive of malignancy.
Therapy was begun with parenteral cloxacil-
lin and ciprofloxacin, but the patient died
shortly after.
This patient’s condition is unlikely to have
been spontaneous (“primary”) bacterial peri-
tonitis, which usually occurs in patients
with liver cirrhosis, portal hypertension and
ascites with high serum–ascites albumin
gradient,1 and occasionally in patients with
malignant ascites.2 However, in our patient,
infection may have originated from the
umbilical metastasis. The umbilicus has a
direct connection with the intra-abdominal
cavity and is also connected to a number of
intra-abdominal organs via embryological
remnants, such as the umbilical vein and the
urachus. Both routes may be involved in the
spread of malignant tumour to the umbili-
cus,3 but spread may also be in the opposite
direction, causing peritonitis.
This diagnosis may be missed by physi-
cians who may not notice anything new in a
patient with longstanding malignant ascites,
and may fail to consider bacterial peritonitis,
a treatable condition.
1 Fernandez J, Bauer TM, Navasa M, Rodes J. Diag-
nosis, treatment and prevention of spontaneous
bacterial peritonitis. Baillieres Best Pract Res Clin
Gastroenterol 2000; 14: 975-990.
2 Isner J, Macdonald JS, Schein PS. Spontaneous
Streptococcus pneumoniae peritonitis in a patient
with metastatic gastric cancer: a case report and
etiologic consideration. Cancer 1977; 39: 2306-
2309.
3 Albano EA, Kanter J. Sister Mary Joseph’s nodule.
N Engl J Med 2005; 352: 1913. ❏
Severe nocturnal bradycardia 
with daytime tachycardia in 
obstructive sleep apnoea
John C Bridgman,* William F Heddle†
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Centre, Flinders Drive, Bedford Park, SA 5042.
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TO THE EDITOR: A 50-year-old morbidly
obese woman (weight, 183 kg; body mass
index, 70 kg/m2) presented after 1 month of
worsening dyspnoea. Risk factors for cardio-
vascular disease included hypertension,
smoking and previous heavy alcohol con-
sumption. She had left ventricular failure
(thought to be due to diastolic dysfunction)
and atrial fibrillation with rapid ventricular
response. There was no evidence of infec-
tion or pulmonary embolism.
A transthoracic echocardiogram showed
normal systolic function, although the
images were poor. Measurement of arterial
blood gases showed a compensated respira-
tory acidosis (PaCO2, 58 mmHg; PaO2,
76 mmHg; pH, 7.39; bicarbonate, 34 mmol/
L; base excess, 8 mmol/L). Administration of
intravenous digoxin, frusemide and heparin
led to some symptomatic improvement.
Cardiac monitoring showed atrial fibrilla-
tion, with ventricular rates of 120–170
beats/minute despite the digoxin treatment.
Overnight, 70 pauses in heartbeat of up to 7
seconds were recorded (Box).
The constellation of the nocturnal rhythm
disturbance, hypercapnia and obesity sug-
gested sleep disordered breathing as a unify-
ing diagnosis. Further questioning revealed
symptoms indicative of obstructive sleep
apnoea. Polysomnography, performed that
night, showed a respiratory disturbance
index (number of apnoeic or hypopnoeic
episodes per hour) of 130 (normal value,
< 15). The longest apnoeic episode was
recorded at 34 seconds. The average mini-
mum oxygen saturation was 84% during
non-REM (rapid eye movement) sleep and
64% during REM sleep. The lowest satura-
tions reached during non-REM and REM
sleep were 64% and 61%, respectively.
These results suggested severe obstructive
sleep apnoea.1
The following night, her condition
improved with application via mask of con-
tinuous positive airway pressure (CPAP) at a
level of 12 cm H2O using room air. Cardiac
monitoring continued to show atrial fibrilla-
tion with high ventricular rates, but no
pauses in heartbeat occurred. This allowed
treatment with atenolol and digoxin to con-
trol the ventricular rate.
At 6-week review, the patient was com-
plying with home CPAP therapy and felt
well. An electrocardiogram confirmed spon-
taneous reversion to sinus rhythm at
70 beats/minute.
There is increasing evidence to suggest a
link between obstructive sleep apnoea and
atrial fibrillation.2 Obstructive sleep apnoea
is also a risk factor for hypertension, coro-
nary artery disease and heart failure, all of
which are known to precipitate atrial fibril-
lation.3,4 Transient heartblock has been
found in 10% of patients with obstructive
sleep apnoea. Pauses of up to 2 seconds are
a predictable physiological response to
inspiratory airflow obstruction and hypoxia.
These pauses are exacerbated by negative
chronotropes. Studies have shown that
bradycardia can be effectively abolished
with mask CPAP therapy.5
Overnight cardiac monitor trace, showing atrial fibrillation and a 7-second pauseMJA • Volume 184 Number 2 • 16 January 2006 93
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this patient suggests that sleep apnoea
caused the significant nocturnal ventricular
pauses and had a role in the aetiology of the
atrial fibrillation.
1 Sleep-related breathing disorders in adults: recom-
mendations for syndrome definition and measure-
ment techniques in clinical research. Report of an
American Academy of Sleep Medicine Task Force.
Sleep 1999; 22: 667-689.
2 Gami AS, Pressman G, Caples SM, et al. Association
of atrial fibrillation and obstructive sleep apnea.
Circulation 2004; 110: 364-367.
3 Peppard PE, Young T, Palta M, Skatrud J. Prospec-
tive study of the association between sleep-disor-
dered breathing and hypertension. N Engl J Med
2000; 342: 1378-1384.
4 Hung J, Whitford EG, Parsons RW, Hillman DR.
Association of sleep apnoea with myocardial infarc-
tion in men. Lancet 1990; 336: 261-264.
5 Koehler U, Fus E, Grimm W, et al. Heart block in
patients with obstructive sleep apnoea: pathoge-
netic factors and effects of treatment. Eur Respir J
1998; 11: 434-439. ❏
More students and less 
patients: the squeeze on 
medical teaching resources
John D Paull
Anaesthestist, Launceston General Hospital, 
PO Box 200, Exeter, TAS 7275. 
jdpaull@intas.net.au
TO THE EDITOR: A black day for the MJA,
I thought, on seeing the title of the article by
Crotty, “More students and less patients: the
squeeze on medical teaching resources”.1
I hesitate, but only briefly, to wave the
Fowler brothers’ classic work at you. The
revised 3rd edition, by the brothers’ proxy,
R W Burchfield, notes that “Regrettable, but
prevalent among some standard as well as
many non-standard speakers, is the use of
less with an unprotected plural noun”.2 He
goes on to give examples, among which
your article title could well appear, and
concludes, “The incorrect use is very wide-
spread and seems likely to be ineradicable,
however regrettable that may be”.
The author of the Editorial is not discuss-
ing an amorphous pile of patients. He is
writing about a countable number of people,
of which, regrettably, fewer are willing to
participate in the education of those they
expect to look after them in later life.
1 Crotty BJ. More students and less patients: the
squeeze on medical teaching resources [editorial].
Med J Aust 2005; 183: 444-445. 
2 Burchfield RW, editor. The new Fowler’s modern
English usage. 3rd ed. Oxford: Clarendon Press,
1996: 295. ❏
Helen Randall
Senior Assistant Editor
The Medical Journal of Australia
IN REPLY: We plead guilty, but knowingly
so. When this article was being proofread,
there was much discussion about this
“regrettable” use of less, but in this instance
a catchy title was preferred to following
Burchfield’s prescription.1 We take comfort
from The Cambridge Australian English style
guide, which notes that “using fewer rather
than less is . . . a stylistic matter rather than
one of correct grammar”.2
1 Burchfield RW, editor. The new Fowler’s modern
English usage. 3rd ed. Oxford: Clarendon Press,
1996: 295.
2 Peters P. The Cambridge Australian English style
guide. Cambridge: Cambridge University Press,
1995: 277. ❏
Intern choices for the first 
graduates of James Cook 
University
Richard B Hays,* Ian Wronski,† Jan 
Veitch,‡ Tamara McCloskey§
* Foundation Dean, † Pro-Vice-Chancellor, ‡ Lecturer in 
Medical Education, § Project Officer, Faculty of 
Medicine, Health and Molecular Sciences, James 
Cook University, Townsville, QLD 4811.
richard.hays@jcu.edu.au
TO THE EDITOR: The School of Medicine
at James Cook University (JCU) was estab-
lished in 1999, based on a case that the
workforce needs of northern Australia
needed to be addressed.1 The model was
based in part on other regional medical
schools in the United States, Canada and
Europe, which had demonstrated that local
student recruitment and training could pro-
duce graduates who prefer to work in either
local or similar regional and rural areas.2
The 6-year undergraduate curriculum at
JCU has achieved considerable success in
recruiting students from rural backgrounds3
and in developing and delivering a rural
curriculum.4
The first cohort of students graduated at
the end of 2005, and the intended locations
of their internship are now known. JCU
students were treated like graduates of other
schools by the intern allocation systems
within each state. Of 58 graduating stu-
dents, 51 (88%) have chosen to remain
within Queensland, with 29 (50%) in the
three North Queensland intern training hos-
pitals, occupying a majority of available
intern places in the region. Twelve (21%)
will work in other regional hospitals in
Queensland and 10 (17%) in a hospital in
Brisbane. Seven will work interstate. Fur-
thermore, most of the 37 students of North
Queensland origin are staying in North
Queensland or adjacent regional centres
(only two are leaving Queensland); and
about half of the Brisbane-origin and inter-
state-origin students are staying in Queens-
land. Hence, while some local students have
chosen to move away, some from other
states have chosen to stay close to where
they moved to study.
Forty-two students (72%) responded to a
brief survey exploring their decisions. The
most popular reasons for choosing the loca-
tion of their internship were proximity to
family and friends, and trying somewhere
different from where they had received their
training. All but five respondents indicated
that they were “likely” or “very likely” to
work somewhere in North Queensland in
the future, depending on the availability of
postgraduate training opportunities.
This outcome suggests that the intended
workforce mission of the school may be
achievable through a combination of selec-
tion and curriculum strategies. A longitud-
inal cohort study is in progress to address
longer-term graduate career choice out-
comes.
1 Hays RB. A new medical school for regional Aus-
tralia. Med J Aust 2000; 172: 362-363.
2 Magnus JH, Tollan A. Rural doctor recruitment:
does medical education in a rural district recruit
doctors to rural areas? Med Educ 1993; 27: 250-253.
3 Hays RB, Bower AJ. Modifying academic ranking of
rural and remote medical school applicants [letter].
Med J Aust 2001; 174: 371-372.
4 Hays RB. Rural initiatives at the James Cook Univer-
sity School of Medicine: a vertically integrated
regional/rural/remote medical education provider.
Aust J Rural Health 2001; 9 Suppl 1: S2-S5. ❏
Problem-based learning: a 
dissemination success story?
Robert G Batey
Professor of Medicine, Faculty of Health, University of 
Newcastle, Locked Bag 119, Wallsend, NSW 2287.
Robert.Batey@hnehealth.nsw.gov.au
TO THE EDITOR: The article by Sanson-
Fisher and Lynagh on problem-based learn-
ing (PBL)1 is very timely, raising important
questions about the popularity and efficacy
of this method.
My “traditional” education included lec-
tures involving 600 students, as well as
small-group sessions on the wards and in
tutorial rooms. The sessions focused on real
patients. Problem-based sessions often deal94 MJA • Volume 184 Number 2 • 16 January 2006
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case histories and laboratory data.
I believe the differences between PBL and
the standard “curriculum” have been over-
stated. The quality of the teacher is a critical
factor that is understated by proponents of
PBL. An excellent teacher can captivate large
groups with highly relevant and exciting
deliveries, and there is nothing to suggest
that such teaching is less effective, stimulat-
ing or encouraging than PBL-based teach-
ing.
The authors challenge the proponents of
PBL to provide evidence that their method-
ology works. It is also time for those who
teach PBL curricula to ask whether this
approach is cost-effective.
With the knowledge base of medical sci-
ence increasing exponentially, it is hard to
understand how students, without some
guidance, can be expected to take on board
the complexities of some of the problems
that they are faced with. Taking a humane
approach and communicating well with
patients are commendable goals, but not if
they are pursued to the point where patients
fail to receive a correct diagnosis and appro-
priate treatment.
Good teaching is provided by good teach-
ers rather than by a particular teaching
approach. The PBL system is just as fallible
as any other system. I applaud the authors
for raising this matter and for asking the
questions they asked. I look forward to
seeing answers provided in the months to
years ahead.
1 Sanson-Fisher RW, Lynagh MC. Problem-based
learning: a dissemination success story? Med J Aust
2005; 183: 258-260. ❏
Barriers to student access to 
patients in a group of teaching 
hospitals
Graham D Tracy
Emeritus Professor of Surgery, University of New South 
Wales, PO Box 720, Port Macquarie, NSW 2444. 
gtracy@bigpond.net.au
TO THE EDITOR: The two excellent articles
in the MJA on an issue important for medi-
cal education provided too few strategies for
improvement.1,2
First, there is a need for a fundamental
attitude change concerning the role of stu-
dent “doctors”. As long as they are viewed as
inexperienced novices, intruding on hapless
“guinea pigs”, barriers will always be found
to reduce access.
Patients should be informed that inter-
view and examination by a student doctor
adds much to the discussion of their prob-
lem, with real clinical advantage for their
care program. Student doctors are usually
grateful for the privilege, and should be
encouraged to be part of the team, and
assured of the value of discussion with
nurses, residents and other team members.
No additional funding should be needed for
such activity.
Secondly, as surgical patients are admitted
on the day of operation, students should
attend the preadmission clinics to help with
fuller evaluation. Most teachers would wel-
come student doctors in their rooms, but
this requires planning. It works best when
there is a separate examining room for stu-MJA • Volume 184 Number 2 • 16 January 2006 95
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dents and patients seeking the added benefit
of re-examination.
Thirdly, although it is difficult to conduct
symptom analysis for someone without
symptoms, much value can be obtained
from rehearsing specific interrogation and
physical examination of all systems in nor-
mal people; for example, family and friends.
It is not surprising that a few students in
exams cannot feel pulses, when they have
never tried to feel their own!
Fourthly, with modest financial compen-
sation, an army of people with abnormal
signs, not in need of treatment, could be
recruited for clinical teaching. This task
could be assigned to a teaching coordinator,
with skills in social interaction, and would
need the cooperation of clinical staff.
1 Crotty BJ. More students and less patients: the
squeeze on medical teaching resources. Med J
Aust 2005; 183: 444-445. 
2 Olson LG, Hill SR, Newby DA. Barriers to student
access to patients in a group of teaching hospitals.
Med J Aust 2005; 183: 461-463. ❏
Use of prescribed medications 
in a South Australian 
community sample
Rohan A Elliott
Clinical Pharmacist, Monash University and Austin 
Health, 381 Royal Parade, Parkville, VIC 3052.
rohan.elliott@vcp.monash.edu.au
TO THE EDITOR: Goldney and Fisher
recently reported data on medication use in
an Australian community sample and esti-
mated the financial savings that could be
made if the number of prescribed medica-
tions was reduced.1
However, the assumption that the average
number of medications per patient could be
reduced ignores the large body of evidence
that has accumulated over recent years dem-
onstrating under-use of beneficial medi-
cines. Under-prescribing has been identified
in the management of a broad range of
chronic conditions, including heart failure,
ischaemic heart disease, hypertension, atrial
fibrillation, asthma, osteoporosis, pain, and
depression.2,3 It has been suggested that
under-use of beneficial therapies may be an
even bigger problem than over-prescribing,
especially in older patients.4,5
As Goldney and Fisher did not collect any
clinical information about their study sub-
jects, no conclusions can be drawn about
whether medications were more frequently
over-prescribed or under-prescribed. Focus-
ing solely on reducing the number of medi-
cations prescribed may be misguided and
may result in poorer health outcomes. A
broader view of prescribing is required,
recognising that problems result from both
over- and under-prescribing, as well as inap-
propriate dose selection and monitoring.5
1 Goldney RD, Fisher LJ. Use of prescribed medica-
tions in a South Australian community sample. Med
J Aust 2005; 183: 251-253. 
2 National Institute of Clinical Studies. Evidence–
practice gaps report. Vol 1. Melbourne: NICS, 2003.
3 National Institute of Clinical Studies. Evidence–
practice gaps report. Vol 2. Melbourne: NICS, 2005.
4 Gurwitz JH. Improving the quality of medication use
in elderly patients. A not-so-simple prescription.
Arch Intern Med 2002; 162: 1670-1672.
5 Rochon PA, Gurwitz JH. Prescribing for seniors.
Neither too much nor too little. JAMA 1999; 281:
113-115. ❏
Robert D Goldney,* Laura J Fisher†
* Professor of Psychiatry, † Research Officer, The 
Adelaide Clinic, Suite 13, 33 Park Terrace, Gilberton, 
SA 5081. robert.goldney@adelaide.edu.au
IN REPLY: We agree that, because of our
research methodology, we could not neces-
sarily assume that any medication prescrip-
tion was inappropriate, and we noted that on
two occasions. However, our economic anal-
ysis addressed only those people using six or
more prescribed medications (mean, 7.8),
and we reported multiple use of same-class
medications, and, at times, use of two differ-
ent preparations of the same medication.
Therefore, we believe our estimate of poten-
tial cost savings to be conservative. Neverthe-
less, we accept that our hypothesis needs
more formal testing using clinical data.
Competing interests: Robert Goldney is on a psy-
chotropic drug advisory board for Wyeth Australia
and Lundbeck Australia, and the study was sup-
ported by the companies noted in the previously-
published Acknowledgements. He has also
received travel assistance from Sanofi-Synthelabo
Australia and speaker fees from several of the
companies named in the Acknowledgements.
Laura Fisher has received part-salary/funding for
data analysis from the companies noted in the
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